Gustavo is a seasoned biopharmaceutical executive who joined Amcyte Pharma in 2020. For 12 years prior, he was at AGC Biologics (former CMC Biologics), where he most recently served as Chief Executive Officer. From 1994 to 2008, Dr. Mahler held senior management positions at Bayer Healthcare in US, Europe and Latin America. He currently is venture partner at Dynamk Capital and serves on the board of directors for AGC Biologics, Absci and Life Science Washington. Dr. Mahler received a PhD in Biochemistry from the University of Buenos Aires, a MBA from the UNED of Madrid and Executive Leadership Certification from MIT Sloan.
